Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65630 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
1,8-Diaza-2,9-diketocyclotetradecane
CAS:Formula:C12H22N2O2Color and Shape:NeatMolecular weight:226.32Ethyl 1-(4-nitrophenyl)-1H-pyrazole-3-carboxylate
CAS:Purity:95.0%Molecular weight:261.236999511718755-Amino-3-methyl-1-quinolin-5-yl-1H-pyrazole-4-carbonitrile
Purity:95.0%Molecular weight:249.27699279785156MDV 3100-d6 (Enzalutamide-d6)
CAS:Controlled Product<p>Applications Isotope labelled MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer.<br></p>Formula:C21H10D6F4N4O2SColor and Shape:NeatMolecular weight:470.48Demethyl Benzydamine Hydrochloride
CAS:Controlled Product<p>Applications A metabolite of Benzydamine (B209950).<br>References Kataoka, S., et al.: Chem. Pharma. Bull., 21, 358 (1973),<br></p>Formula:C18H22ClN3OColor and Shape:Off White SolidMolecular weight:331.842,6-Dichloroformanilide
CAS:Controlled Product<p>Applications 2,6-Dichloroformanilide is an intermediate in the synthesis of N-(2,6-Dichlorophenyl)-carbonimidic Dichloride (D436565). N-(2,6-dichlorophenyl)-carbonimidic Dichloride is an impurity of clonidine (C587130). Chlonidine is α2-Adrenergic agonist. Antihypertensive; analgesic for neuropathic pain.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Roach, A.G., et al.: J. Pharmacol. Exp. Ther., 227, 421 (1983), Glassman, A.H., et al.: Science, 226, 864 (1984), Abounassif, A.M., et al.: Anal. Profiles Drug Subs. Excip., 21, 109 (1992),<br></p>Formula:C7H5Cl2NOColor and Shape:NeatMolecular weight:190.03rac-Praziquanamine
CAS:Controlled Product<p>Applications Praziquanamine, as the main intermediate for synthesizing antiparasitic agent Praziquantel (P702095).<br>References Dong, Y., et al.: Bioorg. Med. Chem. Lett., 20(8), 2481 (2010)<br></p>Formula:C12H14N2OColor and Shape:NeatMolecular weight:202.25242-(2-Chlorophenyl)quinoline-4-carboxylic acid
CAS:Color and Shape:SolidMolecular weight:283.70999145507811,5-Dimethyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:167.164001464843756-Hydroxy Chlorzoxazone-d2
CAS:Controlled Product<p>Applications 6-Hydroxy Chlorzoxazone-d2 is a labeled analogue of 6-Hydroxy Chlorzoxazone (H825120), A major metabolite of chlorzoxazone and formed by the actions of cytochrome P450IIE1.<br>References Twele, et al.: Arzneim.-Forsch., 32, 759 (1982); Peter, et al.: che. Res. Toxicol., 3, 566 (1990)<br></p>Formula:C7H2D2ClNO3Color and Shape:White To BrownMolecular weight:187.584-(thiophen-2-yl)-2,3-dihydro-1H-1,5-benzodiazepine
CAS:Purity:95.0%Molecular weight:228.30999755859375Niclosamide Ethanolamine Salt
CAS:<p>Applications Niclosamide Ethanolamine Salt is an ethanolamine salt of Niclosamide (N395500), which is used as an anthelmintic drug (Cestodes)<br>References Loftsson, T., et al.: J. Pharm. Sci., 85, 1017 (1996), Malik, N., et al.: Anti. Cancer Drugs, 10, 767 (1999), El-Sayed, M., et al.: Pharm. Res., 18, 23 (2001),<br></p>Formula:C13H8Cl2N2O4·C2H7NOColor and Shape:Dark YellowMolecular weight:388.20α-Ethyl Norepinephrine Hydrochloride (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications A bronchodilator.<br>References Daly, J. W., et al.: J. Med. Chem., 9(3), 273 (1966).<br></p>Formula:C10H15NO3·ClHColor and Shape:NeatMolecular weight:233.69N-pyridin-3-yl-2-(tetrahydro-2H-pyran-4-ylcarbonyl)hydrazinecarbothioamide
Molecular weight:280.3500061035156Dehydronitrosonisoldipine
CAS:Controlled Product<p>Impurity Nisoldipine<br>Applications Dehydronitrosonisoldipine is an impurity of Nisoldipine (N489125). Nisoldipine is a dihydropyridine calcium channel blocker and it is antihypertensive and antianginal.<br>References Kazda, S., et al.: Arzneimittel-Forsch., 30, 2144 (1980); Pasanisi, F., et al.: Eur. J. Clin. Pharmacol., 29, 21 (1985); Lam, J., et al.: J. Am. Col. Cardiol., 6, 447 (1985)<br></p>Formula:C20H22N2O5Color and Shape:NeatMolecular weight:370.4N-Nitrosoephedrine-D3
CAS:Controlled ProductFormula:C10D3H11N2O2Color and Shape:White To Off-WhiteMolecular weight:197.249Levetiracetam-d3 (contains d0)
CAS:Controlled Product<p>Applications The labelled (S)-enantiomer of Etiracetam (E932970) and the ethyl analog of Piracetam (P500800). Used as an anticonvulsant.<br>References Gower, A.J., et al.: Eur. J. Pharmacol., 222, 193 (1992), Kasteleijn-Noist Trenite, D.G.A., et al.: Epilepsy Res., 25, 225 (1996), Patsalos, P.N., et al.: Pharmacol. Ther., 85, 77 (2000),<br></p>Formula:C8H11D3N2O2Color and Shape:NeatMolecular weight:170.21Imiquimod
CAS:Controlled Product<p>Applications An immune response modifier. It stimulates the production of interferon-a.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Megyeri, K., et al.: Mol. Cell Biol., 15, 2207, (1995), Witt, P.L., et al.: Cancer Res., 53, 5176 (1993), Edwards, L., et al.: Arch. Dermatol., 134, 25 (1998)<br></p>Formula:C14H16N4Color and Shape:White To Off-WhiteMolecular weight:240.30Descarboxyl Levofloxacin
CAS:Controlled Product<p>Impurity Levofloxacin Descarboxy Impurity<br>Applications A degradation product of Levofloxacin (L360000).<br>References Wong, F., et al.: J. Pharm. Biomed. Anal., 15, 765 (1997), Singh, G., et al.: Pharmazie, 43, 134 (1988), Radi, A., et al.: Talanta, 58, 319 (2002),<br></p>Formula:C17H20FN3O2Color and Shape:Off-White To Light YellowMolecular weight:317.366-(Tetrahydro-2H-pyran-4-ylmethoxy)pyridin-3-amine
CAS:Purity:97.0%Molecular weight:208.26100158691406A77 1726-d4
CAS:Controlled Product<p>Applications The active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function.<br>References Kirsch, B.M., et al.: Arthritis Research and Therapy, 7, 3, R694, (2005)<br></p>Formula:C122H4H5F3N2O2Color and Shape:Off-WhiteMolecular weight:274.23(R)-N-Desacryloyl N-Propionyl Ibrutinib
CAS:<p>Applications (R)-N-Desacryloyl N-Propionyl Ibrutinib is an inhibitor for bruton’s tyrosine kinase.<br>References Pan, Z., et al.: ChemMedChem (2007), 2(1), 58-61<br></p>Formula:C25H26N6O2Color and Shape:NeatMolecular weight:442.516-Amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile
CAS:Purity:98%Molecular weight:445.9100036621094Olanzapine
CAS:Controlled Product<p>Applications Olanzapine is a serotonin (5-HT2) and dopamine (D1/D2) receptor antagonist with anticholinergic activity. Antipsychotic. Neuroprotective product.<br>References Moore, N.A., et al.: Curr. Opin Invest. Drugs, 2, 281 (1993), Baldwin, D.S. and Montgomery, S.A.: Int. Clin. Psychopharmacol., 10, 239 (1995), Tohen, M., et al.: Am. J. Psychiatry, 156, 702 (1999)<br></p>Formula:C17H20N4SColor and Shape:Light Yellow CrystallineMolecular weight:312.43Nadifloxacin
CAS:<p>Applications Fluorinated quinolone antibacterial (topical).<br>References Kurokawa, I., et al.: J. Am. Acad. Dermatol., 25, 674 (1991),<br></p>Formula:C19H21FN2O4Color and Shape:White To Off-WhiteMolecular weight:360.38N1,N3-Bis(descyclohexyl) N1,N3-Bis(trans-4-Hydroxy-Cyclohexyl) Daprodustat
CAS:Controlled Product<p>Impurity Daprodustat Bishydroxylated Metabolite<br>Applications Daprodustat Metabolite is a metabolite of Daprodustat (D193368). Daprodustat is a novel HIF (Hypoxia inducible factor)-prolyl hydroxylase inhibitor.<br>References Olson, E., et al.: Vasc. Med., 19, 473 (2014);<br></p>Formula:C19H27N3O8Color and Shape:NeatMolecular weight:425.43Blonanserin-d5
CAS:Controlled Product<p>Applications Labelled Blonanserin (B595850). A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic.<br>References Oka, T., et al.: Life Sci., 76, 225 (2004), Singh, A., et al.: Int. Med. J., 12, 175 (2005), Ochi, T., et al.: Bioorg. Med. Chem., Lett., 15, 1055 (2005),<br></p>Formula:C23H25D5FN3Color and Shape:NeatMolecular weight:372.53Altretamine
CAS:Controlled Product<p>Applications An antitumor agent which also acts as a chemosterilant for male houseflies and other insects. Antineoplastic.<br>References Chang, S.C., et al.: Science, 144, 57 (1964), Ames, M.M., et al.: Cancer Res., 39, 5016 (1979), D’Incalci, M., et al.: Br. J. Cancer, 41, 630 (1980),<br></p>Formula:C9H18N6Color and Shape:White Crystalline PowderMolecular weight:210.28S-(2-Guanidino-4-thiazolyl)methylisothiourea Dihydrochloride
CAS:Formula:C6H10N6S2·2ClHColor and Shape:NeatMolecular weight:303.236Hydroxymethoxy-N-desmethyl Toremifene
Formula:C26H28ClNO3Purity:>80%Color and Shape:NeatMolecular weight:437.962-(4-Benzyl-morpholin-2-ylmethyl)-isoindole-1,3-dione
CAS:Purity:95.0%Molecular weight:336.3909912109375Diminazene-13C2,15N4 Dihydrochloride (major)
CAS:<p>Applications Labelled Diminazene (D479550). Antiprotozoal (Trypanosoma, Babesia).<br>References Braithwaite, A.W.<br></p>Formula:C1213C2H17Cl2N315N4Color and Shape:Yellow To Dark YellowMolecular weight:360.2(E)-Chlorprothixene-d6 Hydrochloride
CAS:Controlled Product<p>Applications Antipsychotic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Rudy, B.C., et al.: Anal. Profiles Drug Subs., 2, 63 (1973), Bagli, M., et al.: Arzneim.-Forsch., 46, 247 (1996),<br></p>Formula:C18H13D6Cl2NSColor and Shape:NeatMolecular weight:358.36Dolutegravir Sodium
CAS:<p>Applications Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector.<br>References Kobayashi, M. et al. Antimicrob Agents Chemother., 55, 813 (2011); Garrido, C. et al.: Antiviral, Res., 90, 164 (2011); Lenz, J.C.C. et al.: Exp. Opin. Invest. Drugs, 20, 537 (2011)<br></p>Formula:C20H18F2N3O5·NaColor and Shape:NeatMolecular weight:441.365-(1,3-Dioxolan-2-yl)-2-(4-pentylbenzoyl)thiophene
CAS:Purity:97.0%Molecular weight:330.44000244140625Levofloxacin-d3 Sodium Salt
CAS:Controlled Product<p>Applications Levofloxacin-d3 Sodium Salt, is the labeled analogue of Levofloxacin (L360000), an antibiotic used against gram-negative organisms.<br>References Kato, M., et al.: Arzneim.-Forsch., 42, 365 (1992), North, D.S., et al.: Pharmacotherapy, 18, 915 (1998), Hwang, D.G., et al.: Br. J. Ophthalmol., 87, 1004 (2003),<br></p>Formula:C18H16D3FN3NaO4Color and Shape:NeatMolecular weight:386.374-Chloro-2-(4-chlorobenzoyl)-1-(4-methoxyphenyl)hydrazide Benzoic Acid
CAS:<p>Applications An impurity of the anti-inflammatory drug indomnethacin (I641000). Indomethacin inhibits cyclooxygenase (IC50=0.1uM) selectively over liposygenases (IC50=100uM for 5-,12- and 15-LO). A clinically useful NAISD.<br>References Salari, H., et al.: Prostagland. Leukotrienes Med., 13, 53 (1984), Lehmann, J.M., et al.: J. Biol. Chem., 272, 3406 (1997)<br></p>Formula:C21H16Cl2N2O3Color and Shape:NeatMolecular weight:415.271-[2-(2-Hydroxyethoxy)ethyl]piperazine
CAS:Formula:C8H18N2O2Color and Shape:NeatMolecular weight:174.24Semicarbazide-13C,15N2 Hydrochloride
CAS:Controlled Product<p>Applications A labelled metabolite of Nitrofuran.Environmental contaminants; Food contaminants; Heat processing contaminants<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Elliott, J., et al.: J. Pharm. Pharmacol., 41, 37 (1989), Tribalat, L., et al.: Anal. Bioanal. Chem., 386, 2168 (2006), Chu, P., et al.: J. Agric. Food Chem., 55, 2129 (2007),<br></p>Formula:CH515N2NO·ClHColor and Shape:NeatMolecular weight:114.51Clofedanol Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A centrally-acting cough suppressant. It has local anesthetic and antihistamine properties, and may have anticholinergic effects at high doses.<br>References Yuizono, T., et al.: Yakugaku Zasshi, 87, 915 (1967), Nomura, A., et al.: Oyo Yakuri, 8, 119 (1974),<br></p>Formula:C17H20ClNO·ClHColor and Shape:White To Off-WhiteMolecular weight:326.26Loxoprofen-d3
CAS:Controlled Product<p>Applications Loxoprofen-d3, is the labeled analogue of Loxoprofen (L472905), which is non-selective nonsteroidal anti-inflammatory drug (NSAID) that has been effective in reducing atherosclerosis in mice by reducing inflammation.<br>References Masahide H. et al.: J Clin Biochem Nutr., 47, 138 (2010); Noguchi, M. et al.: Biolog. Pharmac. Bull., 28, 2075 (2005); Hyun, J. et al.: Arch. Pharm. Res., 24, 541 (2001);<br></p>Formula:C15H15D3O3Color and Shape:NeatMolecular weight:249.324-Diphenylmethoxypiperidine hydrochloride
CAS:<p>Stability Hygroscopic<br>Applications 4-Diphenylmethoxypiperidine, HCl<br></p>Formula:C18H21NO·ClHColor and Shape:WhiteMolecular weight:303.832-Chloro-2',4'-difluoroacetophenone
CAS:Controlled Product<p>Applications A α-haloacetophenone derivatives tested for inhibition of protein tyrosine phosphatases SHP-1 and PTP1B.<br>References Taylor, S., et al.: Bioorg. Med. Chem., 6, 1457 (1998), Taing, M., et al.: Biochemistry, 38, 3793 (1999), Shen, K., et al.: J. Biol. Chem., 276, 47311 (2001),<br></p>Formula:C8H5ClF2OColor and Shape:NeatMolecular weight:190.57(S)-4-(Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)morpholine
CAS:Purity:98.0%Molecular weight:421.27458077Nitrendipine Propyl Ester
CAS:Controlled Product<p>Applications Nitrendipine Propyl Ester is an analogue of the antihypertensive drug Nitrendipine (N490150). Also, Nitrendipine Propyl Ester is an impurity of antihypertensive Lercanidipine (L179000). Lercanidipine impurity A.<br>References Ashimori, A., et al.: Chem. Pharm. Bull., 39, 108 (1991), Baindur, N., et al.: J. Med. Chem., 36, 3743 (1993), Zhang, B., et al.: Bioorg. Med. Chem. Lett., 20, 805 (2010),<br></p>Formula:C19H22N2O6Color and Shape:NeatMolecular weight:374.39Prothipendyl-d6 Hydrochloride
CAS:Controlled Product<p>Applications A labelled Phenothiazine (P318040) analog. Antipsychotic.<br>References Sartorelli, A.C., et al.: Experientia, 21, 457 ( 1965),<br></p>Formula:C16H13D6N3S•HClColor and Shape:NeatMolecular weight:291.443646(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester
CAS:Controlled Product<p>Applications (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic Acid 1,1-Dimethylethyl Ester is an intermediate used to prepare dipeptidyl peptidase IV (DPP-IV) inhibitors.<br>References Yoshida, T., et al.: Bioorg. Med. Chem., 20, 5705 (2012); Sakashita, H., et al.: Bioorg. Med. Chem., 15, 641 (2007)<br></p>Formula:C13H20N2O4SColor and Shape:NeatMolecular weight:300.37(R)-Lercanidipine-d3 Hydrochloride
CAS:Controlled ProductFormula:C36H39D3ClN3O6Color and Shape:NeatMolecular weight:651.215-Amino-1-(5-chloro-2-pyridinyl)-1H-pyrazole-4-carbonitrile
CAS:Formula:C9H6ClN5Purity:95.0%Color and Shape:SolidMolecular weight:219.635’-Hydroxymethyl 5’-Desmethyl Meloxicam
CAS:Formula:C14H13N3O5S2Color and Shape:NeatMolecular weight:367.40O-Desmethyl Carvedilol
CAS:Controlled Product<p>Applications A metabolite of Carvedilol (C184625), a nonselective β-adrenergic blocker with α1-blocking activity.<br>References Sponer, G., et al.: J. Cardiovasc. Pharmacol., 9, 317 (1987), Fujimaki, M., et al.: Xenobiotica, 20, 1025 (1990), Ruffolo, R., et al.: Eur. J. Clin. Pharmacol., 38, S82 (1990), Clohs, L., et al.: J. Pharm. Biomed. Anal., 31, 407 (2003),<br></p>Formula:C23H24N2O4Color and Shape:NeatMolecular weight:392.454-(4-Phenylbutoxy)benzoic Acid
CAS:Controlled Product<p>Applications 4-(4-PHENYLBUTOXY)BENZOIC ACID (cas# 30131-16-9) is a useful research chemical.<br></p>Formula:C17H18O3Color and Shape:NeatMolecular weight:270.32Hydroxy Dehydro Nifedipine Lactone
CAS:Controlled ProductFormula:C16H12N2O6Color and Shape:NeatMolecular weight:328.284-tert-Butylacetophenone
CAS:Controlled Product<p>Applications 4-tert-Butylacetophenone is an impurity arising in the synthesis of Ebastine (E320000). Ebastine impurity B.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formula:C12H16OColor and Shape:ColourlessMolecular weight:176.252,3-Dichloro-5,6-dicyanobenzoquinone
CAS:<p>Applications An oxidizing agent, especially in steroid synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br></p>Formula:C8Cl2N2O2Color and Shape:NeatMolecular weight:227.0N-(2-Aminoethyl)morpholine
CAS:Formula:C6H14N2OPurity:98%Color and Shape:Solidified mass or fragmentsMolecular weight:130.191Lisinopril Cyclohexyl Analogue
CAS:Controlled Product<p>Impurity Lisinopril EP Impurity F<br>Applications Lisinopril Cyclohexyl Analogue (Lisinopril EP Impurity F) is a Lisinopril (L468985) impurity.<br>References Paraskevas, G., et al.: J. Pharm. Biomed. Anal., 29, 865 (2002),<br></p>Formula:C21H37N3O5Color and Shape:NeatMolecular weight:411.54Des(oxopentyl) Valsartan
CAS:Controlled Product<p>Impurity Valsartan Desvaleryl Impurity<br>Applications An impurity in the synthesis of Valsartan (V095750).<br>References Carini, D., et al.: J. Med. Chem., 34, 2525 (1991), Buhlmayer, P., et al.: Bioorg. Med. Chem. Lett., 4, 29 (1994),<br></p>Formula:C19H21N5O2Color and Shape:WhiteMolecular weight:351.40Desamino Imiquimod N-Oxide
CAS:Controlled Product<p>Impurity Imiquimod USP Related Compound B<br>Applications Desamino Imiquimod N-Oxide (Imiquimod USP Related Compound B) is a pharmacologically active compound related to Imiquimod (I475000), an immune response modifier. It stimulates the production of Interferon-a.<br>References Megyeri, K., et al.: Mol. Cell Biol., 15, 2207, (1995), Witt, P.L., et al.: Cancer Res., 53, 5176 (1993), Edwards, L., et al.: Arch. Dermatol., 134, 25 (1998); Gerster, J. et al.: J. Med. Chem., 48, 3481 (2005);<br></p>Formula:C14H15N3OColor and Shape:NeatMolecular weight:241.29(±)-Mianserin-d3 Hydrochloride (methyl-d3)
CAS:Controlled Product<p>Applications (±)-Mianserin-d3 HCl (methyl-d3) (CAS# 1219804-97-3) is a useful isotopically labeled research compound.<br></p>Formula:C18D3H17N2·ClHColor and Shape:NeatMolecular weight:303.8442Tolcapone-d4
CAS:Controlled Product<p>Applications Orally active inhibitor of central and peripheral catechol-O-methyltransferase (COMT). Antiparkinsonian.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Dingemanse, J., et al.: Clin. Pharmacol. Ther., 57, 508 (1995), Keating, K.A., Drugs, 19, 165 (2005),<br></p>Formula:C14H7D4NO5Color and Shape:NeatMolecular weight:277.27Olaquindox
CAS:<p>Applications A growth stimulant.<br>References Barber, R.S., et al.: Anim. Feed Sci. Technol., 4, 117 (1979), Kwaga, J., et al.: Antimicrob. Agents Chemother., 34, 2423 (1990), Hugot, J., et al.: Lancet, 362, 2012 (2003),<br></p>Formula:C12H13N3O4Color and Shape:NeatMolecular weight:263.253-QUINOLINECARBOXYLIC ACID, 7-[(2-AMINOETHYL)AMINO]-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-4-OXO-
CAS:Purity:97.0%Molecular weight:335.33499145507811,2-Diphenyl Hydrazine
CAS:Controlled Product<p>Stability Air Sensitive (Oxidize)<br>Applications Impurity in the production of Phenylbutazone (P319570). Hydrazobenzene is a metabolic intermediate of Azobenzene.Carcinogenic.<br>References Chung, K., et al.: Mutation Res., 114, 269 (1983), Kawanishi, S., et al.: J. Biol. Chem., 261, 5952 (1986), Floyd, R., et al.: Carcinogenesis, 11, 1447 (1990), Shibutani, S., et al.: Nature, 349, 431 (1991),<br></p>Formula:C12H12N2Color and Shape:OrangeMolecular weight:184.24Nateglinide
CAS:Controlled Product<p>Applications An amino-acid derivative that stimulates insulin secretion. Used as an antidiabetic.<br>References Shinkai, H., et al.: J. Med. Chem., 32, 1436 (1989), Sato, Y., et al.: Diabetes Res. Clin. Pract., 12, 53 (1991), Vicent, D., et al.: J. Clin. Invest., 111, 1373 (2003), Ceriello, A., et al.: Diabet. Med., 21, 171 (2004),<br></p>Formula:C19H27NO3Color and Shape:White To Off-WhiteMolecular weight:317.424-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone
CAS:Controlled Product<p>Impurity Rivaroxaban Impurity E<br>Applications 4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone (Rivaroxaban Impurity E) is an impurity of Rivaroxaban (R538000), which is a antithrombotic agent and a FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formula:C13H17ClN2O3Color and Shape:NeatMolecular weight:284.744'-Methoxyacetophenone
CAS:Controlled ProductFormula:C9H10O2Color and Shape:NeatMolecular weight:150.17(3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-(2,3,5,6-tetradeuterio-4-fluorophenyl)azetidin-2-one
CAS:Controlled Product<p>Applications Labelled Ezetimibe (E975000), an antihyperlipoproteinemic. A Cholesterol absorption inhibitor.<br>References van Heek, M., at al.: J. Pharmacol. Exp. Ther., 283, 157 (1997), van Heek, M., at al.: Brit. J. Pharmacol., 129, 1748 (2000)<br></p>Formula:C242H4H17F2NO3Color and Shape:NeatMolecular weight:413.45Lansoprazole Sulfide N-Oxide
CAS:<p>Applications Used in the preparation of Lansoprazole and its metabolite and impurities.<br>References Reddy, G. et al.; Synthetic Commun. 38, 3477 (2008)<br></p>Formula:C16H14F3N3O2SColor and Shape:Off White SolidMolecular weight:369.36Iprodione
CAS:<p>Applications Fungicide. Iprodione is also used in cannabis testing kits as a component of pesticide mixes (P698240).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Lacroix, L., et al.: Phytiatr.-Phytopharm., 23, 165 (1974), Brenneman, T.B., et al.: Plant Dis., 71, 546 (1987),<br></p>Formula:C13H13Cl2N3O3Color and Shape:NeatMolecular weight:330.17Valsartan
CAS:<p>Stability Hygroscopic<br>Applications A nonpeptide angiotensin II AT1-receptor antagonist. Antihypertensive.<br>References Criscione, L., et al.: Brit. J. Pharmacol., 110, 761 (1993), Muller, P., et al.: Eur. J. Clin. Pharmacol., 47, 231 (1994)<br></p>Formula:C24H29N5O3Color and Shape:NeatMolecular weight:435.524’-(Bromomethyl)biphenyl-2-carboxylic Acid tert-Butyl Ester
CAS:Controlled Product<p>Impurity Telmisartan EP Impurity H<br>Applications 4’-(Bromomethyl)biphenyl-2-carboxylic Acid tert-Butyl Ester (Telmisartan EP Impurity H) is a biphenyl derivative used in the preparation of angiotensin II receptor antagonists. T017000<br>References Wahhab, A. et al.: Arzneim.-Forsch., 43, 1157 (1993); Yanagisawa, H. et al.: J. Med. Chem., 39, 323 (1996);<br></p>Formula:C18H19BrO2Color and Shape:NeatMolecular weight:347.25N-Formyl Trimetazidine
CAS:<p>Stability Hygroscopic<br>Applications N-Formyl Trimetazidine is an impurity of Trimetazidine (T795610).<br>References Szwed, H., et al.: Clin. Drug Invest., 19, 1 (2000), Thoppil, S., et al.: J. Pharm. Biomed. Anal., 25, 15 (2001), Wang, Z., et al.: Pharmazie, 62, 27 (2007),<br></p>Formula:C15H22N2O4Color and Shape:NeatMolecular weight:294.35Palbociclib-d4
CAS:Controlled Product<p>Applications Palbociclib-d4 is an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.<br>References Finn, R., et al.: Breast Cancer Res., 11, 5 (2009)<br></p>Formula:C24H25D4N7O2Color and Shape:Light YellowMolecular weight:451.56(R)-Rabeprazole Sodium Salt
CAS:Controlled Product<p>Applications A partially reversible gastric proton pump inhibitor.<br>References Moda, T., et al.: Lett. Drug Des. Discov., 4, 502 (2007), Belaz, K., et al.: J. Pharm. Biomed. Anal., 47, 81 (2008),<br></p>Formula:C18H20N3NaO3SColor and Shape:NeatMolecular weight:381.422,3,5-Trimethylpyridine N-Oxide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Intermediate in the preparation of Omeprazole metabolites<br></p>Formula:C8H11NOColor and Shape:Off-White To Light BrownMolecular weight:137.18Triallate
CAS:Controlled Product<p>Applications Triallate is a pesticide.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Schneider, M., et al.: J. Environ. Qual., 42, 844 (2013); Busi, R., et al.: Pest Manag. Sci., 69, 1379 (2013)<br></p>Formula:C10H16Cl3NOSColor and Shape:Light Brown To BrownMolecular weight:304.66Mosapride
CAS:Controlled Product<p>Applications A selective 5-HT4 receptor agonist. Gastroprokinetic.<br>References Yoshida, N., et al.: Arch. Int. Pharmacodyn. Ther., 300, 51 (1989), Yatera, S., et al.: Japan. Pharmacol. Ther., 21, 21 (1993), Ruth, M., et al.: Aliment Pharmacol. Ther., 12, 35 (1998),<br></p>Formula:C21H25ClFN3O3Color and Shape:Off White SolidMolecular weight:421.89
![1,3-Bis[4-(2-pyridyl)-2-thiazolyl]benzene](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF098184.webp&w=3840&q=75)
![6-Amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF788588.webp&w=3840&q=75)
![1-[2-(2-Hydroxyethoxy)ethyl]piperazine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH941910.webp&w=3840&q=75)
![(S)-4-(Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)morpholine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF549443.webp&w=3840&q=75)
![3-QUINOLINECARBOXYLIC ACID, 7-[(2-AMINOETHYL)AMINO]-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F10%2Fthumb-webp%2FF386963.webp&w=3840&q=75)
![4-[4-[[(2R)-3-Chloro-2-hydroxypropyl]amino]phenyl]-3-morpholinone](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC292820.webp&w=3840&q=75)
![(3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-(2,3,5,6-tetradeuterio-4…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FE975002.webp&w=3840&q=75)
